Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haider Mahdi

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2014
Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?Ira Winer, Quratulain F Ahmed, Ismail Mert, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
Gynecologic Oncology|March 31, 2023
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinomaRebecca Arend, Jhalak Dholakia, Cesar Castro, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancerMary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
The Journal of Experimental Medicine|August 26, 2017
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumorsCaner Saygin, Andrew Wiechert, Vinay S Rao, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2024
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)Sarah E Taylor, Sarah Behr, Kristine L Cooper, et al.
Gynecologic Oncology|January 24, 2020
Low-grade serous ovarian cancer: State of the scienceBrian Slomovitz, Charlie Gourley, Mark S Carey, et al.
Journal for Immunotherapy of Cancer|November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeBrian Gastman, Piyush K Agarwal, Adam Berger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDeborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2014
Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?Ira Winer, Quratulain F Ahmed, Ismail Mert, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
Gynecologic Oncology|March 31, 2023
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinomaRebecca Arend, Jhalak Dholakia, Cesar Castro, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancerMary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
The Journal of Experimental Medicine|August 26, 2017
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumorsCaner Saygin, Andrew Wiechert, Vinay S Rao, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2024
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)Sarah E Taylor, Sarah Behr, Kristine L Cooper, et al.
Gynecologic Oncology|January 24, 2020
Low-grade serous ovarian cancer: State of the scienceBrian Slomovitz, Charlie Gourley, Mark S Carey, et al.
Journal for Immunotherapy of Cancer|November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeBrian Gastman, Piyush K Agarwal, Adam Berger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDeborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Pageof 9